• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$58.00 $0.59 (1.03%)

REAL-TIME: Last trade at

Quest Diagnostics, Inc.

NYSE:DGX

Jump to this page for:

Related Resources

Many Pregnant Women Not Screened For Chlamydia and Gonorrhea

5/23/2012 by StockHouse

Many Pregnant Women Not Screened For Chlamydia and Gonorrhea

5/23/2012 by StockWatch

Many Pregnant Women Not Screened For Chlamydia and Gonorrhea

5/23/2012 by PR Newswire

Quest Diagnostics Develops CAH Tests

5/18/2012 by Zacks Equity Research Analyst Blog

Quest Diagnostics Develops CAH Tests - Analyst Blog

5/18/2012 by Zacks Investment Research

Barclays' medical supplies and devices analysts hold a conference call

5/18/2012 by Theflyonthewall.com

Many Pregnant Women Not Screened for Chlamydia and Gonorrhea, Study Finds

5/17/2012 by Infection Control Today

Quest Diagnostics introduces four new test panels for CAH

5/17/2012 by Theflyonthewall.com

Quest Diagnostics Extends Endocrine Diagnostic Menu with New Congenital Adrenal Hyperplasia (CAH) Steroid Screening Panels

5/17/2012 by PR Newswire

Quest Diagnostics Reminds Women to Make Their Health a Priority During National Women's Health Week

5/16/2012 by PR Newswire

Vermillion Reports First Quarter 2012 Results

5/15/2012 by Genetic Engineering News

Vermillion Reports First Quarter 2012 Results

5/15/2012 by PR Newswire

Quest Diagnostics Declares Quarterly Cash Dividend

5/11/2012 by StockHouse

Quest Diagnostics Declares Quarterly Cash Dividend

5/11/2012 by StockWatch

Quest Diagnostics, Inc. (DGX) Declares $0.17 Quarterly Dividend; 1.2% Yield

5/11/2012 by StreetInsider.com

Quest Diagnostics Declares Quarterly Cash Dividend

5/11/2012 by PR Newswire

Earnings Scorecard: Quest Diagnostics - Analyst Blog

5/1/2012 by Zacks Investment Research

Earnings Scorecard: Quest Diagnostics

5/1/2012 by Zacks Equity Research Analyst Blog

Quest Diagnostics Sponsors American Cancer Society Choose You® Women's Health Movement

5/1/2012 by PR Newswire

Three in Five Americans Misuse Their Prescription Drugs, Finds National Study of Prescription Medication Lab Testing

4/27/2012 by StockHouse

Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date

4/27/2012 by StockHouse

Three in Five Americans Misuse Their Prescription Drugs, Finds National Study of Prescription Medication Lab Testing

4/27/2012 by StockWatch

Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date

4/27/2012 by StockWatch

Three in Five Americans Misuse Their Prescription Drugs, Finds National Study of Prescription Medication Lab Testing

4/27/2012 by PR Newswire

Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date

4/27/2012 by PR Newswire

Quest Diagnostics: Rx misuse recorded among majority of Americans

4/26/2012 by Drug Store News

Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrig's Disease)

4/25/2012 by Genetic Engineering News

Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrig's Disease)

4/25/2012 by StockHouse

Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrig's Disease)

4/25/2012 by PR Newswire

LabCorp Fighting Industry Headwinds (LH, DGX, HMA, HCA)

4/24/2012 by Investopedia

Survey Finds Women More Likely to Exercise if It Feels Like Play, Not Work

4/23/2012 by StockHouse

Survey Finds Women More Likely to Exercise if It Feels Like Play, Not Work

4/23/2012 by StockWatch

Survey Finds Women More Likely to Exercise if It Feels Like Play, Not Work

4/23/2012 by PR Newswire

Quest Diagnostics and LabCorp mentioned cautiously at UBS

4/20/2012 by Theflyonthewall.com

Quest Sees Solid Pricing and Volume in 1Q Driven by Acquisitions

4/18/2012 by Morningstar

Quest Diagnostics' CEO Discusses Q1 2012 Results - Earnings Call Transcript

4/18/2012 by Seeking Alpha

Quest Beats in 1Q, Ups EPS Guidance - Analyst Blog

4/18/2012 by Zacks Investment Research

Quest Beats in 1Q, Ups EPS Guidance

4/18/2012 by Zacks Equity Research Analyst Blog

Quest Diagnostics revenue guidance seems conservative, says Leerink

4/18/2012 by Theflyonthewall.com

Quest Diagnostics posts 1Q profit as charges fall

4/18/2012 by Bioscience Technology
See More Articles...